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by its functional class (FC) in the Korean health care setting. METHODS: RA-asso-
ciated costs were estimated from a societal perspective. Health care cost was estimated 
using data from National Health Insurance (NHI) Claims Database between January 
1 and December 31, 2008. In order to estimate other health care costs, like traditional 
medicine and physiotherapy, that are not covered under the NHI and non-health care 
costs including transportation, health food and housekeeping services, face-to-face 
interviews were conducted for 202 patients with RA in a large teaching hospital in 
Seoul for 3 months starting from November 18, 2009. RA-related productivity loss 
and quality of life using EQ-5D were also estimated from the survey. Factors associ-
ated with costs as well as quality of life in RA patients were indentiﬁ ed using multiple 
regression and logistic regression. RESULTS: Total annual cost that RA patients 
incurred in 2009 was estimated to be $1.6 billion, of which almost a half was attribut-
able to productivity loss. As the function of RA patients deteriorates, annual per capita 
cost showed an increasing trend (FC I: $3534, FC II: $6057, FC III: $6722, and FC 
IV: $6856) while quality of life was lowered (FC I: 0.673, FC II: 0.502, FC III: 0.294, 
and FC IV: 0.227). Annual per capita cost increased with the deterioration of function 
(P < 0.05) and co-morbidity (P < 0.1). The quality of life was positively correlated 
with functional class (P < 0.05). CONCLUSIONS: RA patients not only incur high 
health care cost but also suffer from signiﬁ cant productivity loss and reduced quality 
of life in Korea. RA patients’ poor function is highly correlated with higher costs and 
lower quality of life.
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OBJECTIVES: Osteoporosis is a prevalent disease, characterized by low bone mass 
and increased fracture risk. In 1993 the economic burden of osteoporosis-related 
fractures in Canada was $1.3 billion dollars, of which $437 million was acute care. 
Our objective was to update the1993 acute care estimates for Canada for non-trau-
matic fractures. METHODS: We used national administrative databases from Cana-
dian Institute for Health Information for ﬁ scal-year ending March 31, 2008 for 
Canadians over age 50. Data sources included the Discharge Abstract Database for 
all acute care hospitalizations in Canada except Quebec; National Ambulatory Care 
Reporting System for all same day surgery, emergency visits/ambulatory services in 
hospital for Ontario. Both data sources were projected nationally using Statistics 
Canada census data. Non traumatic fractures included hip, humerus, vertebral, wrist, 
other sites (ribs/sternum, pelvis, trunk, clavicle, scapula, femur, patella, tibia/ﬁ bula), 
and multiple sites (more than 1 of the preceding). Costs were based on resource 
intensity weights for direct medical costs less physician billings. Physician fees billed 
directly to provincial plans included visits in hospital, diagnostic and surgical interven-
tions. RESULTS: Osteoporotic non-traumatic fractures were responsible for 57,404 
acute care admissions, 112,749 emergency room visits, and 3,433 same day surgeries 
in Canada in 2008. Hip fractures accounted for 50.3% of admissions, wrist fractures 
accounted for 80.8% of same day surgeries, and emergency visits mostly occurred in 
other sites (30.0%), wrist (29.7%) and hip fractures (22.9%). The cost of acute care 
was estimated at $1.2 billion with hip fractures alone costing $619 million. CONCLU-
SIONS: Osteoporosis is a chronic disease that affects a large segment of the adult 
population in Canada and increases the risk for expensive health care utilization for 
Canadians. Since 1993, the acute care cost of osteoporosis-related fractures has risen 
from $437 million to $1.2 billion dollars per year, which represents an increasing 
economic burden for Canada.
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OBJECTIVES: To estimate the burden of post-menopausal osteoporosis-related frac-
ture hospitalizations in France for acute and rehabilitation care. METHODS: Data 
were obtained from the 2008 French Hospital National Database for women aged 
≥50 years. For acute care, criteria were established according to ICD-10 codes related 
to osteoporosis. As the rules of coding are not strictly followed in real practice, an 
additional database analysis was performed to include stays related to surgical man-
agement of hip fractures. Duplicate hospitalizations were excluded. Among women 
that were identiﬁ ed for acute care, we selected those who went in rehabilitation care 
related speciﬁ cally to osteoporosis. We assessed number of hospitalizations and 
patients, proportion of surgical management, length of stay in acute care and number 
of rehabilitation day and costs. Hospital costs were calculated according 2009 national 
hospital tariff and 2000–2001 National Scale of Costs, respectively for acute and 
rehabilitation care (2009c). RESULTS: There were 67,807 acute hospitalizations 
(64,793 patients) and 1,359,863 days for rehabilitation care (31,458 patients) associ-
ated with osteoporosis-related fractures. In acute care, a total of 80% of the hospi-
talizations were associated with the surgical management of fractures and 89% of 
them were transferred in rehabilitation care. The mean (SD) length of stay and days 
of rehabilitation were 12 ± 8 days and 43 ± 31 days, respectively. The overall cost of 
osteoporosis-related fracture hospitalizations was 415,429,993c for acute care, of 
which 6.5% was related to medical devices, and 331,755,797c for rehabilitation care. 
The mean (SD) hospital cost including medical devices, was 6127c ± 2352c per stay 
for acute care and 10,546c ± 7,869c per stay for rehabilitation care. CONCLUSIONS: 
In 2008, osteoporosis-related fracture hospitalizations were associated with a substan-
tial economic burden in France.
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OBJECTIVES: On the basis of current international prevalence, it can be estimated 
that approximately 740,000 of people in Austria over 50 years are affected by osteo-
porosis, of whom around 617,000 are women. With a fracture rate of 19.7 fractures 
per year per 10,000 inhabitants over the age of 65 years, Austria lies within the peak 
for Europe. Within the framework of a burden of illness study we examined the 
ﬁ nancial burden of osteoporosis in Austria. METHODS: We took both direct and 
indirect costs into consideration. Direct costs encompass medical costs such as 
expenses for pharmaceuticals, inpatient and outpatient medical care costs, as well as 
other medical services (e.g., occupational therapies). Non medical direct costs include 
transportation costs and medical devices (e.g., wheel chairs or crutches). Indirect costs 
refer to costs of productivity losses due to absence of work. Moreover, we included 
costs for early retirement and opportunity costs of informal care provided by family 
members. While there exist similar studies for other countries (e.g., Germany), this is 
the ﬁ rst comprehensive study for Austria. For our analysis, we combined data of both, 
ofﬁ cial statistics, expert estimates as well as unique patient surveys that are currently 
conducted in the course of an international osteoporotic fracture study in Austria. 
RESULTS: Our estimation of the total annual costs in the year 2008 imposed by 
osteoporosis in Austria is c470 million. The largest fraction of this amount is incurred 
by acute hospital treatment. Another signiﬁ cant ﬁ gure, accounting for 20% of total 
costs, is the opportunity cost of informal care. CONCLUSIONS: The ﬁ nancial burden 
of osteoporosis in Austria is substantial. Economic evaluations of preventive and 
therapeutic interventions for the speciﬁ c context of Austria are needed to inform health 
policy decision makers.
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OBJECTIVES: Calculate the cost of osteoporosis in postmenopausal women after a 
fracture-related hospitalization for over a 24 months follow-up period. METHODS: 
Retrospective analysis of databases of 8 Italian Local Health Units (4 million beneﬁ -
ciaries). We included female patients (≥65 years) hospitalized for a typical osteoporotic 
fracture or osteoporosis between January 1, 2000 and December 31, 2005. Data were 
collected on hospitalizations, visits, medication and diagnostic tests in the 24 months 
after the ﬁ rst hospitalization. Over this period, treatment compliance measured as 
Medical Possession Ratio was calculated according to the proportion of days covered 
by osteoporosis-related drug treatments and classiﬁ ed as low (≤80%) and high 
(>80%). Relative unit costs for resource use were collected from DGRS, National 
Tariffs and Drugs National Formulary. RESULTS: A total of 10,158 patients were 
included (average age ± SD, 79.0 ± 7.5 years) (overall cost was c70.5 million for the 
ﬁ rst hospitalization). Of these, 98% (n = 9978) were hospitalized for a typical osteo-
porotic fracture and 180 (2%) for osteoporosis. Most were hip fractures (5189 (52%); 
76% of total costs). During 24 months follow-up, 6654 patients (66%) had resource 
utilization data (overall cost was c15.0 million; average cost per patient was c2254). 
Among all 9978 women with fracture, 21% (n = 2119) had a subsequent hospitaliza-
tion for fracture (66% were hip) and this accounted for 89% of the c15.0 million 
(11% other, diagnostic tests). Only 15% (n = 1470) of all evaluated patients received 
osteoporosis-related drug treatment within the six months following discharge and 
bisphosphonates were prescribed to 92.6% of them. Among bisphosphonate-treated 
patients, 33% (n = 459) and 66% (n = 921) displayed a high and low compliance 
level, respectively. CONCLUSIONS: In this database analysis, costs of osteoporosis 
after a ﬁ rst hospitalization for fracture were relevant and mostly due to re-hospital-
ization for a new typical osteoporotic fracture, mainly at the hip site. Exposure and 
compliance to osteoporosis treatment were suboptimal in this patient population.
